KR101857736B1 - Composition of chlorine disinfections free of chlorine smell - Google Patents

Composition of chlorine disinfections free of chlorine smell Download PDF

Info

Publication number
KR101857736B1
KR101857736B1 KR1020160046238A KR20160046238A KR101857736B1 KR 101857736 B1 KR101857736 B1 KR 101857736B1 KR 1020160046238 A KR1020160046238 A KR 1020160046238A KR 20160046238 A KR20160046238 A KR 20160046238A KR 101857736 B1 KR101857736 B1 KR 101857736B1
Authority
KR
South Korea
Prior art keywords
chlorine
disinfectant
virus
sodium
diluted
Prior art date
Application number
KR1020160046238A
Other languages
Korean (ko)
Other versions
KR20170118442A (en
Inventor
정상희
안준영
이지훈
강익재
Original Assignee
호서대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 호서대학교 산학협력단 filed Critical 호서대학교 산학협력단
Priority to KR1020160046238A priority Critical patent/KR101857736B1/en
Publication of KR20170118442A publication Critical patent/KR20170118442A/en
Application granted granted Critical
Publication of KR101857736B1 publication Critical patent/KR101857736B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/08Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/06Aluminium; Calcium; Magnesium; Compounds thereof

Abstract

본 발명은 염소취가 제거된 염소계 살균소독제 조성물에 관한 것으로, 보다 상세하게는 염소계 살균소독제; 및 과산화나트륨, 설파믹산 및 이들의 혼합물 중 선택된 어느 하나의 성분;을 포함하여 염소계 소독제의 우수한 효력을 유지 향상시키면서 염소 냄새를 효과적으로 제거하여 환경친화적이고, 작업자 및 동물에 안전하여 구제역, AI 등의 악성 전염병에 효율적인 적용이 가능한 염소취가 제거된 염소계 살균소독제 조성물에 관한 것이다.More particularly, the present invention relates to a chlorine-based disinfecting and disinfecting composition, and more particularly, to a chlorine- And a component selected from the group consisting of sodium peroxide, sulfamic acid, and a mixture thereof. The chlorine-based disinfectant is excellent in efficacy of the chlorine-based disinfectant and effectively removes the chlorine odor and is environmentally friendly, safe for workers and animals, To a chlorine-based disinfecting and disinfecting composition which is effectively applied to a malicious infectious disease.

Description

염소취가 제거된 염소계 살균소독제 조성물{Composition of chlorine disinfections free of chlorine smell} Technical Field [0001] The present invention relates to a chlorine-based disinfectant composition for chlorine removal,

본 발명은 염소취가 제거된 염소계 살균소독제 조성물에 관한 것으로, 보다 상세하게는 염소계 살균소독제와 과산화나트륨, 설파믹산 및 이들의 혼합물 중 선택된 어느 하나의 성분을 포함하여 염소취가 제거된 염소계 살균소독제 조성물에 관한 것이다.The present invention relates to a chlorine-based disinfecting and disinfecting composition comprising chlorine-based disinfecting disinfectant and chlorine-based disinfecting and disinfecting composition containing chlorine-based disinfecting disinfectant and a component selected from sodium peroxide, sulfamic acid, ≪ / RTI >

살균소독제로서 염소계 살균소독제는 유리염소성분이 세균의 세포막의 투과성에 장애를 주고 원형질 성분을 산화시키며 효소반응을 저해함으로써 강력한 살균력을 발휘하며, 실제로 인체의 면역 시스템에서도 백혈구의 일종인 호중구(Neutrophils)에서 차아염소산(HOCl)을 만들어 세균을 파괴시키는 것을 알려져 있다.The chlorine-based disinfectant as a sterilizing disinfectant exhibits a powerful disinfecting power by inhibiting the permeability of the bacterial cell membranes, oxidizing the protoplasmic components, inhibiting the enzyme reaction, and in fact, the neutrophils (Neutrophils) (HOCl) is known to destroy bacteria by producing hypochlorous acid (HOCl).

염소계 살균소독제는 흔히 락스라고 알려진 차아염소산나트륨(NaOCl)이나, 이산화염소(ClO2), 염소 가스(Cl2), 차아염소산(HOCl), 차아염소산 이온(OCl-) 등의 형태로 살균에 이용되고 있다.Used for sterilization in the form of - chlorine-based sanitizers often Locks known as sodium hypochlorite (NaOCl) or chlorine dioxide (ClO 2), chlorine gas (Cl 2), hypochlorous acid (HOCl), hypochlorite ions (OCl) .

한편, 이염화이소시아눌산나트륨(NaDCC)은 차아염소산보다 약 100배의 효력을 나타내는 성분으로, 100% 생분해되어 잔류되지 않아 환경에 악영향을 끼치지 않으며 발포성 산제로서 탄산소다와의 상승작용으로 더 한층 소독효과를 증진시킨다고 알려져 있다.On the other hand, sodium dicarboxylate sodium (NaDCC) is a component showing about 100 times more effective than hypochlorous acid, and does not adversely affect the environment because it is 100% biodegradable and does not adversely affect the environment. As synergistic action with sodium carbonate as a foaming agent, It is known to promote the disinfection effect.

한편, NaDCC 소독제의 경우 우수한 소독효과 및 안전한 사용 및 직접적인 가축적용 등 우수한 제품력을 가지고 있으나, 사용 시 염소냄새를 발생시켜 방역기관 및 축산농가에서 수요 확대가 제한적이었다. 따라서, 이들 NaDCC 소독제가 살균소독의 광범위한 유효성 외에 탈취 및 악취제거의 효능이 부가된다면 그 사용이 더욱 확대될 수 있고, 소독제에 의한 잔존 냄새가 제거된다면 이상적인 가축전용 살균소독제로 각광받을 수 있을 것이다.On the other hand, NaDCC disinfectants have superior productive power such as excellent disinfection effect, safe use and direct livestock application, but the demand of the anti-virus and livestock farmers was limited due to the generation of chlorine smell during use. Accordingly, these NaDCC disinfectants may be used as an ideal disinfectant for livestock only if the effect of deodorization and odor removal is added in addition to the wide effectiveness of sanitizing disinfection, and if the residual odor due to the disinfectant is removed.

국내등록특허 제10-1054947호Korean Patent No. 10-1054947

이에 본 발명은 염소계 소독제의 우수한 효력을 유지 향상시키면서 염소 냄새를 효과적으로 제거한 염소취가 제거된 염소계 살균소독제 조성물을 제공하는 것을 목적으로 한다. Accordingly, it is an object of the present invention to provide a chlorine-based disinfecting and disinfecting composition in which the chlorine-based disinfectant is effectively removed and the chlorine odor is effectively removed while maintaining the excellent effect of the chlorine-based disinfectant.

또한 본 발명은 환경친화적이고, 작업자 및 동물에 안전하여 구제역, AI 등의 악성 전염병에 효율적인 적용이 가능한 염소취가 제거된 염소계 살균소독제 조성물을 제공하는 것을 목적으로 한다.It is another object of the present invention to provide a chlorine-based disinfectant composition which is environmentally friendly, safe for workers and animals, and can be effectively applied to malignant infectious diseases such as foot-and-mouth disease and AI.

상기 목적을 달성하기 위하여, 본 발명은 염소계 살균소독제; 및 과산화나트륨, 설파믹산 및 이들의 혼합물 중 선택된 어느 하나의 성분;을 포함하는 염소취가 제거된 염소계 살균소독제 조성물을 제공한다.In order to accomplish the above object, the present invention provides a chlorine-based disinfectant; And a component selected from the group consisting of sodium peroxide, sulfamic acid, and mixtures thereof.

본 발명에 따르면 염소계 소독제의 우수한 효력을 유지 향상시키면서 염소 냄새를 효과적으로 제거되어 환경 친화적이고, 작업자 및 동물에 안전하여 구제역, AI 등의 악성 전염병 효율적인 적용이 가능한 염소취가 제거된 염소계 살균소독제를 제공할 수 있다.According to the present invention, there is provided a chlorine-based disinfectant which is effective in removing chlorine odor effectively while maintaining and improving the effectiveness of a chlorine disinfectant, and is environmentally friendly, safe for workers and animals, and can effectively apply malignant infectious diseases such as foot- can do.

이하 본 발명을 상세히 설명한다. Hereinafter, the present invention will be described in detail.

본 발명은 염소계 살균소독제; 및 과산화나트륨, 설파믹산 및 이들의 혼합물 중 선택된 어느 하나의 성분;을 포함하는 염소취가 제거된 염소계 살균소독제 조성물을 제공한다.The present invention relates to a chlorine-based sanitizing disinfectant; And a component selected from the group consisting of sodium peroxide, sulfamic acid, and mixtures thereof.

상기 과산화나트륨, 설파믹산 또는 이들의 혼합물은 염소계 살균소독제에 사용되어 물속의 유리염소를 치환하여 염소계 화합물을 안정화시킴으로써 염소계 화합물로부터 발생하는 염소 냄새를 저감화시킨다.Sodium peroxide, sulfamic acid, or a mixture thereof is used in a chlorine-based disinfecting disinfectant to stabilize a chlorine-based compound by substituting free chlorine in water, thereby reducing a chlorine-containing odor generated from the chlorine-based compound.

상기 과산화나트륨 또는 설파믹산은 염소계 살균소독제에 단독으로 사용될 수도 있으나, 보다 효과적인 염소취 제거와, 소독제 사용 이후의 잔존하는 염소취의 제거를 위해서는 과산화나트륨과 설파믹산을 병용하는 것이 가장 바람직하다. 이때, 상기 과산화나트륨과 설파믹산은 1~10:2~20의 중량비로 혼합하여 사용하는 것이 최적의 염소취 제거효과 발현에 있어 바람직하다.The sodium or sulfamic acid may be used alone in a chlorine-based disinfecting disinfectant, but it is most preferable to use sodium peroxide and a sulfamic acid together in order to more effectively remove chlorine and remove residual chlorine after use of the disinfectant. At this time, it is preferable to mix the sodium peroxide and the sulfamic acid in a weight ratio of 1: 10: 2 to 20 in order to exhibit optimal chlorine scavenging effect.

상기 과산화나트륨, 설파믹산 또는 이들의 혼합물은 염소계 살균소독제에 사용된 염소계 화합물의 종류에 따라 그 함량을 적절히 조절하여 사용할 수 있으며, 예를 들어 조성물 총 100중량부에 대하여 10~50중량부로 포함될 수 있으며, 바람직하게는 20~40중량부로 포함되는 것이다. 그 함량이 10중량부 미만일 경우에는 염소냄새가 발생할 수 있으며, 50중량부를 초과할 경우에는 소독력이 낮아질 수 있다.The content of sodium peroxide, sulfamic acid, or a mixture thereof may be appropriately controlled depending on the type of the chlorine-based compound used in the chlorine-based disinfectant, for example, 10 to 50 parts by weight per 100 parts by weight of the composition And preferably 20 to 40 parts by weight. If the content is less than 10 parts by weight, chlorine odor may occur. If the content is more than 50 parts by weight, the disinfecting power may be lowered.

상기 염소계 살균소독제는 통상 탈색, 표백, 살균, 소독 등의 목적으로 염소계 살균소독제에 사용되는 화합물이면 그 종류가 제한되지 않으며, 예를 들어 이염화이소시아눌산나트륨(sodium dichloroisocyanurate, NaDCC), 트리클로로이소시아눌산(trichloroisocyanuric acid), 차아염소산 칼슘(calcium hypochlorite), 염소수(chlorine water), 차아염소산나트륨(sodium hypochlorite), 차아염소산(sodium hypochlorite) 등을 사용할 수 있다. 살균소독 효과의 발현을 위해서 바람직하게는 이염화이소시아눌산나트륨, 차아염소산 등을 사용하는 것이며, 특히 이염화이소시아눌산나트륨을 사용하는 것이 가장 바람직하다.The type of the chlorine-based disinfecting disinfectant is not limited as long as it is a compound used in a chlorine-based disinfecting disinfectant for the purpose of decolorizing, bleaching, sterilizing, disinfecting, etc. For example, sodium dichloroisocyanurate (NaDCC), trichloroisocyanurate Trichloroisocyanuric acid, calcium hypochlorite, chlorine water, sodium hypochlorite, sodium hypochlorite and the like can be used. Sodium dicarboxylate, hypochlorous acid or the like is preferably used for the development of the disinfecting effect, and sodium dicarboxylate is most preferably used.

상기 염소계 살균소독제는 조성물 총 100중량부에 대하여 50~80중량부로 포함될 수 있다.The chloric sterilizing disinfectant may be contained in an amount of 50 to 80 parts by weight based on 100 parts by weight of the total composition.

상기와 같은 본 발명의 염소계 살균소독제 조성물은 기존 염소계 살균소독제가 사용되던 모든 대상에 적용하여 세균, 바이러스 등을 살균 및 소독할 수 있음은 물론이다. 특히, 본 발명의 염소계 살균소독제는 동물에 적용되어 살모넬라 타이피뮤리움(Salmonella typhimurium) 등과 같은 살모넬라속, 브루셀라 오비스(Brucella ovis) 등과 같은 브루셀라속, 클로스트리디움 퍼프리젠스(Clostridium perfringens) 등과 같은 클로스티리디움속 세균 등의 세균류 또는 이들의 변종; 조류인플루엔자바이러스(Avian influenza virus, AI), 뉴캐슬병바이러스(Newcastle disease virus, ND), 돼지 유행성 설사증 바이러스(Porcine epidemic diarrhea virus, PED), 돼지 호흡기 및 생식 증후군 바이러스(Porcine respiratory and reproductive syndrome virus, PRRS), 구제역 바이러스(Foot and mouth disease virus, FMD) 등의 바이러스류 또는 이들의 변종의 살균, 소독을 위해 사용될 수 있다. It is needless to say that the chlorine-based disinfecting and disinfecting composition of the present invention can sterilize and disinfect bacterium, virus and the like by applying it to all the objects to which the conventional chlorine-based disinfecting and disinfecting agent is used. In particular, the chlorine-based disinfectant of the present invention is applied to an animal and is used as an antiseptic agent such as Clostridium perfringens such as Salmonella genus such as Salmonella typhimurium, Brucella genus such as Brucella ovis , Bacterium such as bacteria of the genus Tyridium, or variants thereof; Avian influenza virus (Avian influenza virus, AI), Newcastle Disease virus (Newcastle disease virus, ND), porcine epidemic diarrhea virus (Porcine epidemic diarrhea virus, PED) , porcine respiratory and reproductive syndrome virus (Porcine respiratory and reproductive syndrome virus, PRRS) , Foot and mouth disease virus (FMD), or the like, or a variant thereof.

또한 본 발명은 필요에 따라 통상의 염소계 살균소독제에 사용되는 산제제, 염기성 제제 등을 포함할 수 있다.In addition, the present invention may include an acid preparation, a basic preparation and the like, which are used in conventional chlorine-based disinfecting disinfectants, if necessary.

상기 산제제는 통상의 살균소독제에 사용되는 성분이면 그 종류가 제한되지 않으며, 예를 들어 아디핀산, 무수 시트릭산 등을 사용할 수 있다. The kind of the acid preparation is not limited as long as it is a component used in a conventional disinfectant, and for example, adipic acid, citric anhydride and the like can be used.

상기 산제제는 조성물 총 100중량부에 대하여 10~40중량부로 포함될 수 있으며, 바람직하게는 20~30중량부로 포함되는 것이다.The acid preparation may be included in an amount of 10 to 40 parts by weight, preferably 20 to 30 parts by weight, based on 100 parts by weight of the total composition.

상기 염기성 제제는 통상의 살균소독제에 사용되는 성분이면 그 종류가 제한되지 않으며, 예를 들어 중탄산나트륨, 무수탄산나트륨, 탄산수소나트륨, 수산화나트륨, 과탄산나트륨 등을 사용할 수 있다.The type of the basic agent is not limited as long as it is a component used in a conventional disinfectant, for example, sodium bicarbonate, anhydrous sodium carbonate, sodium hydrogen carbonate, sodium hydroxide, sodium percarbonate and the like can be used.

상기 염기성 제제는 조성물 총 100중량부에 대하여 5~25중량부로 포함될 수 있으며, 바람직하게는 10~20중량부로 포함되는 것이다.The basic agent may be included in an amount of 5 to 25 parts by weight, preferably 10 to 20 parts by weight, based on 100 parts by weight of the total composition.

또한 본 발명은 과산화나트륨, 설파믹산 등의 작용에 영향을 주지 않으며, 염소취 제거에 효과가 있는 성분을 추가로 더 포함할 수 있다. 추가 가능한 성분으로는 비타민 C(ascobic acid), 과산화수소(hydrogen peroxide), 탄산수소나트륨(sodium bicarbonate), 탄산나트륨(sodium carbonate), 구연산(citric acid) 등이 있으며, 그 함량은 필요에 따라 적절히 조절하여 사용할 수 있다.Further, the present invention may further include a component that does not affect the action of sodium peroxide, sulfamic acid, etc., and is effective in removing chlorine. The ingredients that can be added include ascorbic acid, hydrogen peroxide, sodium bicarbonate, sodium carbonate, citric acid and the like. Can be used.

본 발명에 따르면 상기와 같은 염기성 화합물, 산제제 및 염기성 제제를 포함하는 염소계 살균소독제에 과산화나트륨, 설파믹산 또는 이들의 혼합물이 함께 사용되어 기존 염소계 살균소독제의 문제점이었던 염소 냄새를 효과적으로 제거할 수 있어 작업자나 살균소독제가 적용되는 동물에의 사용이 안전하고 용이할 수 있으며, 더욱이 살균소독제 사용 이후에도 염소 냄새가 잔존하지 않아 사용의 범위가 광범위하게 확장될 수 있다. According to the present invention, chlorine-based disinfecting disinfectants including basic compounds, acid formulations and basic formulations are used together with sodium peroxide, sulfamic acid or a mixture thereof to effectively remove the chlorine odor, which has been a problem of the conventional chlorine- It is safe and easy to use it in an animal to which an operator or disinfectant is applied. Moreover, since the chlorine odor does not remain even after the disinfectant is used, the range of use can be extended widely.

즉, 본 발명의 염소취가 제거된 살균소독제는 광범위한 살균소독의 유효성과 염소취 제거 효능을 가져 국내 뿐 아니라 구제역, AI 등 악성 전염병이 잘 발생되는 해외 각국으로의 수출이 가능하다. That is, the chlorine scavenging disinfectant of the present invention has a wide range of disinfection effectiveness and chlorine scavenging efficacy, so that it can be exported to various countries where malignant infectious diseases such as foot-and-mouth disease and AI are well developed in Korea.

이하에서는 실시예를 들어 본 발명에 관하여 더욱 상세하게 설명할 것이나. 이들 실시예는 단지 설명의 목적을 위한 것으로 본 발명의 보호 범위를 제한하고자 하는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to examples. These embodiments are for purposes of illustration only and are not intended to limit the scope of protection of the present invention.

실시예 1. 염소계 살균소독제 제조-1Example 1. Production of chlorine-based disinfectant 1

이염화이소시아눌산나트륨 650g, 설파믹산 250g 및 과산화나트륨 100g을 혼합하여 염소계 살균소독제를 제조하였다.A chlorine disinfectant was prepared by mixing 650 g of sodium dichloroisocyanurate, 250 g of sulfamic acid and 100 g of sodium peroxide.

실시예 2. 염소계 살균소독제 제조-2Example 2. Production of chlorine-based disinfectant 2

이염화이소시아눌산나트륨 600g, 설파믹산 270g, 중탄산나트륨 100g 및 무수탄산나트륨 30g을 혼합하여 염소계 살균소독제를 제조하였다.Chlorinated disinfectant was prepared by mixing 600 g of sodium dichloroisocyanurate, 270 g of sulfamic acid, 100 g of sodium bicarbonate and 30 g of anhydrous sodium carbonate.

비교예 1. 염소계 살균소독제Comparative Example 1. Chlorine-based disinfectant

이염화이소시아눌산나트륨 500g, 아디핀산 240g, 중탄산나트륨 220g 및 무수탄산나트륨 40g으로 이루어진 (주)동방의 애니가드를 사용하였다.Aniguard Co., Ltd., consisting of 500 g of sodium dichloroisocyanurate, 240 g of adipic acid, 220 g of sodium bicarbonate and 40 g of anhydrous sodium carbonate, was used.

실험예 1. 살균소독제의 염소취 측정Experimental Example 1. Chlorine measurement of the disinfectant

상기 실시예 1~2 및 비교예 1의 살균소독제를 물과 1:10~500의 배율로 희석한 후 Honeywell의 휴대용 Cl2 측정기인 MINIMAX-XP-Cl2를 이용하여 염소취를 측정하고, 그 결과를 하기 표 1에 나타내었다. The sanitizing and disinfecting agents of Examples 1 and 2 and Comparative Example 1 were diluted with water at a magnification of 1: 10-500 and chlorine was measured using MINIMAX-XP-Cl 2 , a portable Cl 2 measuring instrument of Honeywell, The results are shown in Table 1 below.

Figure 112016036246608-pat00001
Figure 112016036246608-pat00001

상기 표 1에 나타낸 바와 같이, 본 발명에 따라 과산화나트륨, 설파믹산 또는 이들의 혼합물이 첨가된 실시예 1 내지 2의 살균소독제는 염소계 화합물을 사용하고도 전 희석배율에서 염소취의 발생이 없었으나, 기존 염소계 살균소독제인 비교예 1의 경우 희석비율에 무관하게 염소냄새를 나타냄을 확인할 수 있었다. As shown in Table 1, chlorine-based compounds were used in the disinfectant disinfectants of Examples 1 and 2, in which sodium peroxide, sulfamic acid, or a mixture thereof was added according to the present invention, , And the chlorine-based disinfectant, Comparative Example 1, exhibited chlorine odor irrespective of the dilution ratio.

이같은 결과로부터, 과산화나트륨, 설파믹산 또는 이들의 혼합물을 포함하는 본 발명의 염소계 살균소독제는 염소취의 발생이 없어 사용이 안전할 것임을 알 수 있었다. From these results, it was found that the chlorine-based disinfectant of the present invention containing sodium peroxide, sulfamic acid or a mixture thereof was safe to use without chlorine scavenging.

실험예 2. 염소취 제거 기전 확인Experimental Example 2. Confirmation of chlorine removal mechanism

상기 실시예 1 또는 2의 살균소독제의 염소취 제거 기전을 확인하고, 그 결과를 하기 표 2에 나타내었다.The chlorine scavenging mechanism of the disinfectant of Example 1 or 2 was confirmed, and the results are shown in Table 2 below.

구분division 반응식Reaction formula NaDCCNaDCC C3Cl2N3NaO3+H2O -> C3H3N3O3+HOClC 3 Cl 2 N 3 NaO 3 + H 2 O -> C 3 H 3 N 3 O 3 + HOCl 실시예 1Example 1 H2NSO3H+Na2O2+C3Cl2N3NaO3+H2O
→ H2NSO3H+Na2O2+C3H3N3O3+HOCl
→ H2NO2+Na2SO3+H20+C3Cl2N3NaO3
H 2 NSO 3 H + Na 2 O 2 + C 3 Cl 2 N 3 NaO 3 + H 2 O
H 2 NSO 3 H + Na 2 O 2 + C 3 H 3 N 3 O 3 + HOCl
→ H 2 NO 2 + Na 2 SO 3 + H 2 O + C 3 Cl 2 N 3 NaO 3
실시예 2Example 2 H2NSO3H+C3Cl2N3NaO3+NaHCO3+Na2CO3+H2O
→ H2NSO3H+NaHCO3+Na2CO3+C3H3N3O3+HOCl
→ Na2CO3+C3Cl2N3NaO3+H2O+NaSO3
H 2 NSO 3 H + C 3 Cl 2 N 3 NaO 3 + NaHCO 3 + Na 2 CO 3 + H 2 O
H 2 NSO 3 H + NaHCO 3 + Na 2 CO 3 + C 3 H 3 N 3 O 3 + HOCl
→ Na 2 CO 3 + C 3 Cl 2 N 3 NaO 3 + H 2 O + NaSO 3

본 발명에서 염소계 화합물로 사용된 이염화이소시아눌산나트륨(NaDCC)은 물과 반응 시 비해리형 염소산으로서 염소취의 원인이 되는 HOCl을 형성한다. 그러나, 본 발명의 염소계 살균소독제의 경우에는 상기 표 2에 나타낸 바와 같이 과산화나트륨, 설파믹산 또는 이들의 혼합물을 포함하여 염소취의 원인 물질인 HOCl을 형성하지 않았으며, 이 결과 염소취 제거 효과를 발현함을 알 수 있었다. The sodium dicarboxylate sodium (NaDCC) used as the chlorine compound in the present invention forms HOCl which is a cause of chlorine scavenging as the diluted chloric acid when reacting with water. However, in the case of the chlorine-based disinfectant of the present invention, as shown in Table 2, HOCl, which is a causative substance of chlorine odor including sodium peroxide, sulfamic acid or a mixture thereof, was not formed. Respectively.

실험예 3. 세균류 살균소독의 유효 희석배율 도출Experimental Example 3: Effective Dilution Scale of Bacterial Disinfection

3-1. 3-1. Salmonella typhimuriumSalmonella typhimurium 에 대한 살균소독력Sterilization disinfection power for

세균의 배양에는 고압멸균된 Nutrient agar에 살모넬라 타이피뮤리움(Salmonella typhimurium)을 도말하여 37±2℃에서 20시간 동안 배양하였다. 배양된 살모넬라 타이피뮤리움을 20mL Nutrient broth가 담긴 시험관에 접종하여 37±2℃에서 20시간 동안 진탕배양하였다. 배양한 세균은 사용 직전까지 37℃로 유지시켰으며, 사용 세균의 농도는 mL당 1×108CFU 이상이었다.For bacterial culture, high pressure sterilized Nutrient agar was added to Salmonella typhimurium ) and cultured at 37 ± 2 ° C for 20 hours. The cultured Salmonella typhimurium was inoculated into a test tube containing 20 mL of Nutrient broth and incubated with shaking at 37 ± 2 ° C. for 20 hours. The cultured bacteria were kept at 37 ° C until just before use, and the concentration of bacteria used was more than 1 × 10 8 CFU per mL.

상기 실시예 1~2 및 비교예의 살균소독제를 경수(증류수 1L에 CaCl2 0.305g과 MgCl2·6H2O 0.139g(w/v)이 함유되게 조제)와 유기물(경수에 yeast 5%(w/v)가 함유되게 조제)을 이용하여 다음과 같이 희석하였다. 실시예 1의 살균소독제는 경수를 이용하여 4,100, 4,500, 5,000, 5,600, 6,200의 배율로 희석하였고, 유기물을 이용하여 70, 75, 8, 95, 100의 배율로 희석하였다. 실시예 2의 살균소독제는 경수를 이용하여 4,100, 4,500, 5,000, 5,600, 6,200의 배율로 희석하였고, 유기물을 이용하여 60, 70, 75, 85, 95의 배율로 희석하였다. 또한 비교예의 살균소독제는 경수를 이용하여 12,000, 13,500, 15,000, 16,500, 18,500의 배율로 희석하였고, 유기물을 이용하여 60, 70, 75, 85, 95의 배율로 희석하였다.The sterilization disinfectants of Examples 1 to 2 and Comparative Example were immersed in a water-containing solution (1 L of distilled water, CaCl 2 0.305 g of MgCl 2 .6H 2 O and 0.139 g (w / v) of MgCl 2 .6H 2 O) and organic matter (prepared to contain yeast 5% (w / v) in hard water). The sterilization disinfectant of Example 1 was diluted at 4, 100, 4,500, 5,000, 5,600, and 6,200 magnifications using hard water and diluted at 70, 75, 8, 95, and 100 magnifications using organic matter. The disinfectant of Example 2 was diluted with water at 4, 100, 4,500, 5,000, 5,600, and 6,200 magnifications and diluted with organic matter to 60, 70, 75, 85, and 95 magnifications. In addition, the disinfectant of the comparative example was diluted at a magnification of 12,000, 13,500, 15,000, 16,500, and 18,500 using hard water and diluted with an organic material at a magnification of 60, 70, 75, 85 and 95.

이후, 37℃에서 배양한 세균 4mL를 경수 또는 5% 유기물 희석액 96mL에 각각 혼합하였다. 상기 혼합액 중 2.5mL를 취하여 실시예 1~2 및 비교예의 각 소독제 희석액(4℃) 2.5mL에 넣고 혼합한 후, 4℃에서 정확히 30분간 반응시켰다. 이때, 각 시험관 처리는 차례대로 1분의 간격으로 실시하였으며, 반응 중 10분마다 흔들어주었다. 또한 병원체 대조군은 소독제 희석액이 없는 경수를 사용하였다.Then, 4 mL of the bacteria cultured at 37 째 C were mixed with 96 mL of dilute hydrochloric acid or 5% organic material, respectively. 2.5 mL of the mixed solution was added to 2.5 mL of the disinfectant solution (4 DEG C) of each of the disinfectant solutions of Examples 1 and 2 and Comparative Example, mixed and reacted at 4 DEG C for exactly 30 minutes. At this time, each test tube treatment was performed at intervals of 1 minute, and shaking was performed every 10 minutes during the reaction. In the pathogen control group, hard water without sterilant diluent was used.

반응이 끝난 즉시 1mL을 꺼내어 미리 37℃에 넣어 놓은 9mL의 중화배지(Nutrient broth에 비동화된 말혈청 5%(v/v) 포함되게 조제)에 넣고 혼합하였다. 그 다음, 각 소독제 희석단계별로 5mL씩 5개를 준비하여 Nutrient broth 시험관에 0.1mL씩 접종한 후 37℃ 배양기에서 48시간 동안 배양하였다.Immediately after the reaction was completed, 1 mL was taken out and mixed in 9 mL of neutralization medium (containing 5% (v / v) of horse serum unmixed in Nutrient broth) preliminarily placed at 37 ° C. Next, 5 mL of each disinfectant dilution step was prepared, and 0.1 mL of each was inoculated into a Nutrient broth tube and cultured in a 37 ° C incubator for 48 hours.

3-2. 3-2. Brucella ovisBrucella ovis 에 대한 살균소독력Sterilization disinfection power for

세균의 배양에는 고압멸균된 5% Sheep blood agar에 브루셀라 오비스(Brucella ovis)를 도말하여 37±2℃에서 20시간 동안 배양하였다. 배양된 브루셀라 오비스를 20mL Brain heart infusion broth가 담긴 시험관에 접종하여 37±2℃에서 20시간 동안 진탕배양하였다. 배양한 세균은 사용 직전까지 37℃로 유지시켰으며, 사용 세균의 농도는 mL당 1×108CFU 이상이었다. Brucella ovis was plated on high pressure sterilized 5% Sheep blood agar and cultured at 37 ± 2 ° C for 20 hours. The cultured Brucella ovis was inoculated into a test tube containing 20 mL of Brain heart infusion broth and incubated at 37 ± 2 ° C. for 20 hours with shaking. The cultured bacteria were kept at 37 ° C until just before use, and the concentration of bacteria used was more than 1 × 10 8 CFU per mL.

상기 실시예 1~2 및 비교예의 살균소독제를 경수(증류수 1L에 CaCl2 0.305g과 MgCl2·6H2O 0.139g(w/v)이 함유되게 조제)와 유기물(경수에 yeast 5%(w/v)가 함유되게 조제)을 이용하여 다음과 같이 희석하였다. 실시예 1의 살균소독제는 경수를 이용하여 2,500, 2,800, 3,000, 3,500, 4,000의 배율로 희석하였고, 유기물을 이용하여 80, 90, 10, 11, 12의 배율로 희석하였다. 실시예 2의 살균소독제는 경수를 이용하여 1,600, 1,800, 2,000, 2,200, 2,500의 배율로 희석하였고, 유기물을 이용하여 60, 70, 75, 85, 95의 배율로 희석하였다. 또한 비교예의 살균소독제는 경수를 이용하여 4,100, 4,500, 5,000, 5,600, 6,200의 배율로 희석하였고, 유기물을 이용하여 40, 45, 50, 55, 62의 배율로 희석하였다.The sterilization disinfectants of Examples 1 to 2 and Comparative Example were immersed in a water-containing solution (1 L of distilled water, CaCl 2 0.305 g of MgCl 2 .6H 2 O and 0.139 g (w / v) of MgCl 2 .6H 2 O) and organic matter (prepared to contain yeast 5% (w / v) in hard water). The disinfectant of Example 1 was diluted with water at 2,500, 2,800, 3,000, 3,500, and 4,000, and diluted with organic materials at 80, 90, 10, 11, and 12 magnifications. The sterilization disinfectant of Example 2 was diluted with water at a dilution ratio of 1,600, 1,800, 2,000, 2,200, and 2,500, and diluted with organic matter at a ratio of 60, 70, 75, 85, and 95. In addition, the disinfectant of Comparative Example was diluted with water at 4, 100, 4,500, 5,000, 5,600, and 6,200, and diluted with organic matter at 40, 45, 50, 55 and 62 magnifications.

이후, 37℃에서 배양한 세균 4mL를 경수 또는 5% 유기물 희석액 96mL에 각각 혼합하였다. 상기 혼합액 중 2.5mL를 취하여 실시예 1~2 및 비교예의 소독제 희석액(4℃) 각각 2.5mL씩에 넣고 혼합한 후, 4℃에서 정확히 30분간 반응시켰다. 이때, 각 시험관 처리는 차례대로 1분의 간격으로 실시하였으며, 반응 중 10분마다 흔들어주었다. 또한 병원체 대조군은 소독제 희석액이 없는 경수를 사용하였다.Then, 4 mL of the bacteria cultured at 37 째 C were mixed with 96 mL of dilute hydrochloric acid or 5% organic material, respectively. 2.5 mL of the mixed solution was added to 2.5 mL of each of the disinfectant diluents (4 ° C.) of Examples 1 and 2 and Comparative Example, and the mixture was reacted at 4 ° C. for exactly 30 minutes. At this time, each test tube treatment was performed at intervals of 1 minute, and shaking was performed every 10 minutes during the reaction. In the pathogen control group, hard water without sterilant diluent was used.

반응이 끝난 즉시 1mL을 꺼내어 미리 37℃에 넣어 놓은 9mL의 중화배지(Nutrient broth에 비동화된 말혈청 5%(v/v) 포함되게 조제)에 넣고 혼합하였다. 그 다음, 각 소독제 희석단계별로 5mL씩 5개를 준비하여 Brain heart infusion broth 시험관에 0.1mL씩 접종한 후 37℃ 배양기에서 120시간 동안 배양하였다.Immediately after the reaction was completed, 1 mL was taken out and mixed in 9 mL of neutralization medium (containing 5% (v / v) of horse serum unmixed in Nutrient broth) preliminarily placed at 37 ° C. Next, 5 mL of each disinfectant dilution step was prepared, 0.1 mL of each was inoculated into a Brain heart infusion broth tube, and then cultured in a 37 ° C. incubator for 120 hours.

3-3. 3-3. Clostridium perfringensClostridium perfringens 에 대한 살균소독력Sterilization disinfection power for

세균의 배양에는 고압멸균된 5% Sheep blood agar에 클로스트리디움 퍼프리젠스(Clostridium perfringens)를 도말하여 37±2℃인 혐기성균 배양장치에서 20시간 동안 배양하였다. 배양된 클로스트리디움 퍼프리젠스를 20mL NIH thioglycollate broth가 담긴 시험관에 접종하여 37±2℃에서 혐기성균 배양장치에서 20시간 동안 진탕배양하였다. 배양한 세균은 사용 직전까지 37℃로 유지시켰으며, 사용 세균의 농도는 mL당 1×108CFU 이상이었다.For culturing of bacteria, Clostridium perfringens was plated on high pressure sterilized 5% Sheep blood agar and incubated in an anaerobic culture apparatus at 37 ± 2 ° C for 20 hours. The cultured Clostridium pertussis was inoculated into a test tube containing 20 mL of NIH thioglycollate broth and cultured in an anaerobic culture incubator at 37 賊 2 属 C for 20 hours with shaking. The cultured bacteria were kept at 37 ° C until just before use, and the concentration of bacteria used was more than 1 × 10 8 CFU per mL.

상기 실시예 1~2 및 비교예의 살균소독제를 경수(증류수 1L에 CaCl2 0.305g과 MgCl2·6H2O 0.139g(w/v)이 함유되게 조제)와 유기물(경수에 yeast 5%(w/v)가 함유되게 조제)을 이용하여 다음과 같이 희석하였다. 실시예 1의 살균소독제는 경수를 이용하여 2,000, 2,300, 2,500, 2,700, 3,000의 배율로 희석하였고, 유기물은 25, 27, 30, 33, 37의 배율로 희석하였다. 실시예 2의 살균소독제는 경수를 이용하여 2,300, 2,500, 2,700, 3,000, 3,300의 배율로 희석하였고, 유기물을 이용하여 25, 27, 30, 33, 37의 배율로 희석하였다. 또한 비교예의 살균소독제는 경수를 이용하여 6,000, 7,000, 7,500, 8,500, 9,500의 배율로 희석하였고, 유기물을 이용하여 25, 27, 30, 33, 37의 배율로 희석하였다.The sterilization disinfectants of Examples 1 to 2 and Comparative Example were immersed in a water-containing solution (1 L of distilled water, CaCl 2 0.305 g of MgCl 2 .6H 2 O and 0.139 g (w / v) of MgCl 2 .6H 2 O) and organic matter (prepared to contain yeast 5% (w / v) in hard water). The sterilization disinfectant of Example 1 was diluted with water at 2,000, 2,300, 2,500, 2,700, and 3,000 magnifications, and the organic matter was diluted at 25, 27, 30, 33, and 37 magnifications. The disinfectant of Example 2 was diluted with water at a dilution rate of 2,300, 2,500, 2,700, 3,000, and 3,300 and diluted with organic matter at 25, 27, 30, 33, and 37 magnifications. In addition, the disinfectant of the comparative example was diluted with water at a ratio of 6,000, 7,000, 7,500, 8,500, and 9,500, and diluted with organic matter at 25, 27, 30, 33, and 37 magnifications.

이후, 37℃에서 배양한 세균 4mL를 목적에 맞게 경수 또는 5% 유기물 희석액 96mL에 각각 혼합하였다. 상기 혼합액 중 2.5mL를 취하여 실시예 1~2 및 비교예의 소독제 희석액(4℃) 각각 2.5mL씩에 넣고 혼합한 후, 4℃에서 정확히 1시간 동안 반응시켰다. 이때, 각 시험관 처리는 차례대로 1분의 간격으로 실시하였으며, 반응 중 10분마다 흔들어주었다. 또한 병원체 대조군은 소독제 희석액이 없는 경수를 사용하였다.Then, 4 mL of the bacteria cultured at 37 째 C were mixed with 96 mL of diluted water or 5% organic material, respectively, according to the purpose. 2.5 mL of the mixed solution was added to 2.5 mL of each of the disinfectant diluents (4 ° C.) of Examples 1 and 2 and Comparative Example, mixed and reacted at 4 ° C. for exactly one hour. At this time, each test tube treatment was performed at intervals of 1 minute, and shaking was performed every 10 minutes during the reaction. In the pathogen control group, hard water without sterilant diluent was used.

반응이 끝난 즉시 1mL을 꺼내어 미리 37℃에 넣어 놓은 9mL 중화배지(NIH thioglycollate broth에 비동화된 말혈청 5%(v/v) 포함되게 조제)에 넣고 혼합하였다. 그 다음, 각 소독제 희석단계별로 5mL씩 5개를 준비하여 NIH thioglycollate broth 시험관에 0.1mL씩 접종한 후 37℃ 혐기성 배양기에서 48시간 동안 배양하였다.Immediately after the reaction was completed, 1 mL was taken out and mixed in 9 mL of neutralization medium (prepared to contain 5% (v / v) of horse serum unmixed in NIH thioglycollate broth) previously placed at 37 ° C and mixed. Next, 5 mL of each disinfectant dilution step was prepared, and 0.1 mL of each was inoculated into NIH thioglycollate broth tube and incubated for 48 hours in an anaerobic incubator at 37 ° C.

3-4. 실험결과3-4. Experiment result

상기 3-1 내지 3-3의 배양 후 각 세균의 증식여부를 육안으로 관찰하고, 5개의 동일 소독제 희석배율의 영양배지에서 4개 이상 세균이 증식되지 않은 소독제 희석배율을 최종 유효 희석배율로 판정하고, 그 결과를 하기 표 3에 나타내었다. After the cultivation of 3-1 to 3-3, the growth of each bacterium was visually observed, and the dilution magnification of the disinfectant which did not multiply four or more bacteria in the nutrient medium of five identical disinfectant dilution magnification was judged as the final effective dilution magnification And the results are shown in Table 3 below.

Figure 112016036246608-pat00002
Figure 112016036246608-pat00002

상기 표 3에 나타낸 바와 같이, 본 발명의 염소계 살균소독제는 살모넬라 타이피뮤리움(Salmonella typhimurium ), 브루셀라 오비스(Brucella ovis) 및 클로스트리디움 퍼프리젠스(Clostridium perfringens)의 세균류에 대하여 우수한 살균소독력을 나타내었으며, 비교예 1과 대비하여 염소취가 전혀 없으면서도 유사한 수준의 희석배율에서 유효한 살균소독력을 나타냄을 확인할 수 있었다.As shown in Table 3, the chlorine-based disinfectant of the present invention is Salmonella typhimurium), Orbis brucellosis (Brucella ovis and Clostridium perfringens . It was confirmed that, compared with Comparative Example 1, effective disinfecting power was obtained at a dilution ratio similar to that of Comparative Example 1, even without chlorination at all there was.

실험예 4. 바이러스류 살균소독의 유효 희석배율 도출Experimental Example 4. Derivation of Effective Dilution Factor for Vaccine Disinfection

4-1. 4-1. Avian influenza virusAvian influenza virus (AI)(AI) H9N2에 대한 살균소독력Disinfection power for H9N2

냉동보관 된 조류인플루엔자바이러스(Avian influenza virus, AI)를 녹인 후 사용직전까지 단시간 동안 4℃에 보관하였다.Frozen Avian influenza virus (AI) was dissolved and stored at 4 ℃ for a short time until immediately before use.

상기 실시예 1~2 및 비교예의 살균소독제를 경수(증류수 1 L에 CaCl2 0.305g과 MgCl2·6H2O 0.139g(w/v)이 함유되게 조제)와 유기물(경수에 소태아혈청 5%(v/v)가 함유되게 조제)을 이용하여 다음과 같이 희석하였다. 실시예 1의 살균소독제는 경수를 이용하여 3,000, 4,000, 5,000의 배율로 희석하였고, 유기물을 이용하여 1,800, 2,000, 2,200의 배율로 희석하였다. 실시예 2의 살균소독제는 경수를 이용하여 6,000, 7,000, 8,000의 배율로 희석하였고, 유기물을 이용하여 1,600, 1,800, 2,000의 배율로 희석하였다. 비교예의 살균소독제는 경수를 이용하여 6,000, 7,000, 8,000의 배율로 희석하였고, 유기물을 이용하여 900, 1,100, 1,400의 배율로 희석하였다.The sterilization disinfectants of Examples 1 to 2 and Comparative Examples were immersed in hard water (containing 0.305 g of CaCl 2 and 0.139 g (w / v) of MgCl 2 .6H 2 O in 1 L of distilled water) and an organic material (fetal calf serum 5 % (v / v)) as follows. The sterilization disinfectant of Example 1 was diluted at 3,000, 4,000 and 5,000 magnifications using light water and diluted at 1,800, 2,000 and 2,200 magnifications using organic matter. The sterilization disinfectant of Example 2 was diluted with water at 6,000, 7,000, and 8,000 magnifications and diluted with organic matter at 1,600, 1,800, and 2,000 magnifications. The disinfectant of Comparative Example was diluted with water at 6,000, 7,000, and 8,000 magnifications and diluted with organic matter at 900, 1,100, and 1,400 magnifications.

이후, 4℃에서 보관한 바이러스액 1.0mL(1×10~1×107EID50/mL)를 바이러스 희석용 용액인 경수 또는 유기물 19mL에 넣고 각각 혼합하였다. 상기 바이러스액 중 2.5mL를 취하여 동량의 실시예 1~2 및 비교예의 소독제 희석액이 들어 있는 시험관에 각각 넣어 혼합한 후(총 5mL) 4℃에서 정확히 30분간 반응시켰다. 이때, 각 시험관 처리는 차례대로 1분의 간격으로 실시하였으며, 반응 중 10분마다 흔들어주었다. 또한 병원체 대조군은 소독제 희석액이 없는 경수를 사용하였고, 독성 대조군은 경수로 희석된 소독제 희석액을 사용하였다.Thereafter, 1.0 mL (1 × 10 1 to 1 × 10 7 EID 50 / mL) of virus solution stored at 4 ° C. was added to 19 mL of hard water or organic matter, which is a virus dilution solution, and mixed. 2.5 mL of the virus solution was added to each test tube containing the same amount of the disinfectant solution of Examples 1 and 2 and the comparative example, respectively (5 mL in total), and reacted at 4 ° C for exactly 30 minutes. At this time, each test tube treatment was performed at intervals of 1 minute, and shaking was performed every 10 minutes during the reaction. The pathogen control group used hard water without sterilant diluent, and the toxic control group used light water diluted disinfectant diluent.

반응이 끝난 즉시 1mL을 꺼내어 미리 37℃에 넣어 놓은 5mL 중화배지(PBS에 비동화된 소태아혈청 10%(v/v) 포함되게 조제)에 넣고 혼합하였다. 그 다음, 중화반응을 한 용액을 PBS를 사용하여, 원액, 10-1, 10-2, 10-3, 10-4, 10-5의 농도로 희석하고, 희석배율 당 5개씩 준비하여 9~10일 발육란에 0.2mL로 요막강 내로 접종하였다. Immediately after the reaction was completed, 1 mL was taken out and mixed in 5 mL neutralization medium (prepared so as to contain 10% (v / v) fetal bovine serum unmixed with PBS) previously placed at 37 ° C and mixed. Then, the neutralized solution was diluted with PBS to a concentration of 10 -1 , 10 -2 , 10 -3 , 10 -4 , and 10 -5 , and 5 dilutions per dilution were prepared. 10 days in the developmental field.

접종 후 37℃에서 5일 동안 배양하며 매일 검란을 실시하고, 접종 24시간 이내에 죽은 발육란은 사고사로 간주하여 시험성적에서 제외하였다. 접종 24시간 후부터 5일 이내에 죽은 접종란은 모두 4℃에 보관하였다.After inoculation, the cells were incubated at 37 ° C for 5 days, and the cells were sacrificed every day. The dead cells within 24 hours of inoculation were regarded as accidents and excluded from the test results. All the inoculated dead cells within 24 hours of inoculation within 5 days were stored at 4 ℃.

접종 5일 후까지 살아남은 모든 발육란과 4℃에 보관된 죽은 접종란으로부터 요막강액을 각각 채취하고, 1% 닭적혈구를 사용한 혈구응집반응을 실시하여 바이러스의 존재 유무 및 바이러스 역가를 최종 판정하였고. Karber method로 바이러스 함유량을 계산하였다. After 5 days of inoculation, all of the surviving bovine blastocysts and dead cells from 4 ° C were collected from the urethral lumen and the hemagglutination reaction was carried out using 1% chicken erythrocytes. The virus content was calculated using the Karber method.

병원체 대조군은 경수조건에서 소독제 없이 실험하고 중화반응 단계에서 병원체의 역가가 2×10EID50/mL 이상임을 확인하였다. 독성대조군에서는 살균소독제에 의한 종란독성이 일어나지 않음을 확인하였다.The pathogen control group was tested in the light water condition without the disinfectant and the neutralization reaction step showed that the activity of the pathogen was 2 × 10EID 50 / mL or more. In the toxic control group, it was confirmed that no bacterial toxicity by the disinfectant disinfectant occurred.

4-2. 4-2. Newcastle disease virusNewcastle disease virus (ND) LsSota에 대한 살균소독력(ND) Disinfection power against LsSota

냉동보관 된 뉴캐슬병바이러스(Newcastle disease virus, ND)를 녹인 후 사용직전까지 단시간 동안 4℃에 보관하였다. Newcastle disease virus (ND), a cryopreserved Newcastle disease virus , was dissolved and stored at 4 ° C for a short time until immediately before use.

상기 실시예 1~2 및 비교예의 살균소독제를 경수(증류수 1 L에 CaCl2 0.305g과 MgCl2·6H2O 0.139g(w/v)이 함유되게 조제)와 유기물(경수에 소태아혈청 5%(v/v)가 함유되게 조제)을 이용하여 다음과 같이 희석하였다. 실시예 1의 살균소독제는 경수를 이용하여 4,000, 6,000, 8,000의 배율로 희석하였고, 유기물을 이용하여 600, 1,000, 1,400의 배율로 희석하였다. 실시예 2의 살균소독제는 경수를 이용하여 3,000, 4,000, 6,000의 배율로 희석하였고, 유기물을 이용하여 600, 1,000, 1,400의 배율로 희석하였다. 또한 비교예의 살균소독제는 경수를 이용하여 6,000, 8,000, 12,000의 배율로 희석하였고, 유기물을 이용하여 500, 600, 1,000의 배율로 희석하였다.The sterilization disinfectants of Examples 1 to 2 and Comparative Examples were immersed in hard water (containing 0.305 g of CaCl 2 and 0.139 g (w / v) of MgCl 2 .6H 2 O in 1 L of distilled water) and an organic material (fetal calf serum 5 % (v / v)) as follows. The disinfectant of Example 1 was diluted with water at 4,000, 6,000, and 8,000 magnifications and diluted with organic matter at 600, 1,000, and 1,400 magnifications. The disinfectant of Example 2 was diluted with water at 3,000, 4,000, and 6,000 magnifications and diluted with organic matter at 600, 1,000, and 1,400 magnifications. In addition, the disinfecting disinfectant of the comparative example was diluted with water at 6,000, 8,000, and 12,000 magnifications and diluted with organic matter at 500, 600 and 1,000 magnifications.

이후, 4℃에서 보관한 바이러스액 1.0mL(1×10~1×107EID50/mL)를 바이러스 희석용 용액인 경수 또는 유기물 19mL에 넣고 각각 혼합하였다. 상기 바이러스액 중 2.5mL를 취하여 동량의 실시예 1~2 및 비교예의 소독제 희석액이 들어 있는 시험관에 각각 넣어 혼합한 후(총 5mL) 4℃에서 정확히 30분간 반응시켰다. 이때, 각 시험관 처리는 차례대로 1분의 간격으로 실시하였으며, 반응 중 10분마다 흔들어주었다. 또한 병원체 대조군은 소독제 희석액이 없는 경수를 사용하였고, 독성 대조군은 경수로 희석된 소독제 희석액을 사용하였다.Thereafter, 1.0 mL (1 × 10 1 to 1 × 10 7 EID 50 / mL) of virus solution stored at 4 ° C. was added to 19 mL of hard water or organic matter, which is a virus dilution solution, and mixed. 2.5 mL of the virus solution was added to each test tube containing the same amount of the disinfectant solution of Examples 1 and 2 and the comparative example, respectively (5 mL in total), and reacted at 4 ° C for exactly 30 minutes. At this time, each test tube treatment was performed at intervals of 1 minute, and shaking was performed every 10 minutes during the reaction. The pathogen control group used hard water without sterilant diluent, and the toxic control group used light water diluted disinfectant diluent.

반응이 끝난 즉시 1mL을 꺼내어 미리 37℃에 넣어 놓은 5mL 중화배지(PBS에 비동화된 소태아혈청 10%(v/v) 포함되게 조제)에 넣고 혼합하였다. 그 다음, 중화반응을 한 용액을 PBS를 사용하여, 원액, 10-1, 10-2, 10-3, 10-4, 10-5의 농도로 희석하고, 희석배율 당 5개씩 준비하여 9~10일 발육란에 0.2mL로 요막강 내로 접종하였다.Immediately after the reaction was completed, 1 mL was taken out and mixed in 5 mL neutralization medium (prepared so as to contain 10% (v / v) fetal bovine serum unmixed with PBS) previously placed at 37 ° C and mixed. Then, the neutralized solution was diluted with PBS to a concentration of 10 -1 , 10 -2 , 10 -3 , 10 -4 , and 10 -5 , and 5 dilutions per dilution were prepared. 10 days in the developmental field.

접종 후 37℃에서 5일 동안 배양하며 매일 검란을 실시하고, 접종 24시간 이내에 죽은 발육란은 사고사로 간주하여 시험성적에서 제외하였다. 접종 24시간 후부터 5일 이내에 죽은 접종란은 모두 4℃에 보관하였다.After inoculation, the cells were incubated at 37 ° C for 5 days, and the cells were sacrificed every day. The dead cells within 24 hours of inoculation were regarded as accidents and excluded from the test results. All the inoculated dead cells within 24 hours of inoculation within 5 days were stored at 4 ℃.

접종 5일 후까지 살아남은 모든 발육란과 4℃에 보관된 죽은 접종란으로부터 요막강액을 각각 채취하고, 1% 닭적혈구를 사용한 혈구응집반응을 실시하여 바이러스의 존재 유무 및 바이러스 역가를 최종 판정하였고. Karber method로 바이러스 함유량을 계산하였다. After 5 days of inoculation, all of the surviving bovine blastocysts and dead cells from 4 ° C were collected from the urethral lumen and the hemagglutination reaction was carried out using 1% chicken erythrocytes. The virus content was calculated using the Karber method.

병원체 대조군은 경수조건에서 소독제 없이 실험하고 중화반응 단계에서 병원체의 역가가 2×10EID50/mL 이상임을 확인하였다. 독성대조군에서는 살균소독제에 의한 종란독성이 일어나지 않음을 확인하였다.The pathogen control group was tested in the light water condition without the disinfectant and the neutralization reaction step showed that the activity of the pathogen was 2 × 10EID 50 / mL or more. In the toxic control group, it was confirmed that no bacterial toxicity by the disinfectant disinfectant occurred.

4-3. 4-3. Porcine epidemic diarrhea virusPorcine epidemic diarrhea virus (PED)에 대한 살균소독력(PED)

시험을 수행하기 전 Vero cell(antibiotic·antimycotic을 함유한 α-MEM를 배양 배지로 사용)을 2×105cell/mL이 되도록 96 well plate에 200μL씩 분주하여 37℃, 5% CO2 조건의 배양기에서 배양하였다.Before testing, 200 μL of Vero cell (using α-MEM containing antibiotic and antimycotic as a culture medium) was dispensed in a 96-well plate at 2 × 10 5 cells / mL and incubated at 37 ° C in 5% CO 2 Lt; / RTI >

상기 실시예 1~2 및 비교예의 살균소독제를 경수(증류수 1 L에 CaCl2 0.305g과 MgCl2·6H2O 0.139g(w/v)이 함유되게 조제)와 유기물(경수에 소태아혈청 5%(v/v)가 함유되게 조제)을 이용하여 다음과 같이 희석하였다. 실시예 1의 살균소독제는 경수를 이용하여 30,000, 40,000, 50,000의 배율로 희석하였고, 유기물을 이용하여 400, 800, 1,200의 배율로 희석하였다. 실시예 2의 살균소독제는 경수를 이용하여 30,000, 40,000, 50,000의 배율로 희석하였고, 유기물을 이용하여 800, 1,200, 1,600의 배율로 희석하였다. 또한 비교예의 살균소독제는 경수를 이용하여 30,000, 40,000, 50,000의 배율로 희석하였고, 유기물을 이용하여 100, 200, 400의 배율로 희석하였다.The sterilization disinfectants of Examples 1 to 2 and Comparative Examples were immersed in hard water (containing 0.305 g of CaCl 2 and 0.139 g (w / v) of MgCl 2 .6H 2 O in 1 L of distilled water) and an organic material (fetal calf serum 5 % (v / v)) as follows. The disinfectant of Example 1 was diluted with water at a ratio of 30,000, 40,000, and 50,000, and diluted with organic matter at a ratio of 400, 800 and 1,200. The sterilization disinfectant of Example 2 was diluted with water at 30,000, 40,000, and 50,000 magnifications and diluted with organic matter at 800, 1,200, and 1,600 magnifications. In addition, the sterilizing disinfectant of the comparative example was diluted with water at 30,000, 40,000 and 50,000 magnifications, and diluted with organic matter at 100, 200 and 400 magnifications.

이후, 4℃에서 보관한 바이러스액 1.0mL(1×10~1×107EID50/mL)를 바이러스 희석용 용액인 경수 또는 유기물 19mL에 넣고 각각 혼합하였다. 상기 바이러스액 중 2.5mL를 취하여 동량의 실시예 1~2 및 비교예의 소독제 희석액이 들어 있는 시험관에 각각 넣어 혼합한 후(총 5mL) 4℃에서 정확히 30분간 반응시켰다. 이때, 각 시험관 처리는 차례대로 1분의 간격으로 실시하였으며, 반응 중 10분마다 흔들어주었다. 또한 병원체 대조군은 소독제 희석액이 없는 경수를 사용하였고, 독성 대조군은 경수로 희석된 소독제 희석액을 사용하였다.Thereafter, 1.0 mL (1 × 10 1 to 1 × 10 7 EID 50 / mL) of virus solution stored at 4 ° C. was added to 19 mL of hard water or organic matter, which is a virus dilution solution, and mixed. 2.5 mL of the virus solution was added to each test tube containing the same amount of the disinfectant solution of Examples 1 and 2 and the comparative example, respectively (5 mL in total), and reacted at 4 ° C for exactly 30 minutes. At this time, each test tube treatment was performed at intervals of 1 minute, and shaking was performed every 10 minutes during the reaction. The pathogen control group used hard water without sterilant diluent, and the toxic control group used light water diluted disinfectant diluent.

반응이 끝난 즉시 1mL을 꺼내어 미리 37℃에 넣어 놓은 5mL 중화배지(antibiotic·antimycotic을 함유한 α-MEM에 비동화된 소태아혈청 10%(v/v) 포함되게 조제)에 넣고 혼합하였다. 그 다음, 중화반응을 한 용액을 바이러스 배지(antibiotic·antimycotic을 함유한 α-MEM에 0.3%(v/v) tryptose phosphate boroth, 0.02%(v/v) yeast extract 및 2㎍/mL trypsin이 함유되게 조제)를 사용하여, 원액, 10-1, 10-2, 10-3, 10-4, 10-5의 농도로 희석하고, 희석배율 당 8well의 monolayer(80~90%)가 형성된 vero cell에 각각 100μL씩 접종하였다. Immediately after the reaction was completed, 1 mL was taken out and mixed in 5 mL of neutralization medium (containing 10% (v / v) of fetal bovine serum immobilized on α-MEM containing antibiotic and antimycotic) Then, the neutralization reaction solution was added to a viral medium containing 0.3% (v / v) tryptose phosphate boroth, 0.02% (v / v) yeast extract and 2 μg / mL trypsin in a viral medium containing antibiotic antimycotic The diluted solution was diluted to a concentration of 10 -1 , 10 -2 , 10 -3 , 10 -4 and 10 -5 using a stock solution of vero cell (80-90%) with 8 wells per dilution Respectively.

접종 후 37℃에서 5일 동안 배양하며 매일 CPE 형성 여부를 관찰하였고, Karber method로 바이러스 함유량을 계산하였다. After inoculation, the cells were incubated at 37 ° C for 5 days. CPE formation was observed daily, and the virus content was calculated by the Karber method.

병원체 대조군은 경수조건에서 소독제 없이 실험하고 중화반응 단계에서 병원체의 역가가 2×105TCID50/mL 이상임을 확인하였다. 독성대조군에서는 살균소독제에 의한 세포독성이 일어나지 않음을 확인하였다.The pathogen control was tested in the light water condition without the disinfectant and the neutralization reaction step confirmed that the activity of the pathogen was more than 2 × 10 5 TCID 50 / mL. In the toxic control group, it was confirmed that no cytotoxicity was caused by the disinfectant disinfectant.

4-4. 4-4. Porcine respiratory and reproductive syndrome virusPorcine respiratory and reproductive syndrome virus (PRRS)에 대한 살균소독력(PRRS)

시험을 수행하기 전 Porcine Alveolar Macrophage cell(antibiotic·antimycotic을 함유한 RPMI-1640을 배양 배지로 사용)을 2×105cell/mL이 되로록 96 well plate에 200μL씩 분주하여 37℃, 5% CO2 조건의 배양기에서 배양하였다.Prior to the test, 200 μL of each well of a 96-well plate was plated at 2 × 10 5 cells / mL in a Porcine Alveolar Macrophage cell (using RPMI-1640 containing antibiotic / antimycotic as a culture medium) 2 < / RTI > conditions.

상기 실시예 1~2 및 비교예의 살균소독제를 경수(증류수 1 L에 CaCl2 0.305g과 MgCl2·6H2O 0.139g(w/v)이 함유되게 조제)와 유기물(경수에 소태아혈청 5%(v/v)가 함유되게 조제)을 이용하여 다음과 같이 희석하였다. 실시예 1의 살균소독제는 경수를 이용하여 10,000, 16,000, 20,000의 배율로 희석하였고, 유기물은 2,000, 2,400, 3,000의 배율로 희석하였다. 실시예 2의 살균소독제는 경수를 이용하여 10,000, 16,000, 20,000의 배율로 희석하였고, 유기물을 이용하여 2,000, 2,400, 3,000의 배율로 희석하였다. 또한 비교예의 살균소독제는 경수를 이용하여 10,000, 16,000, 20,000의 배율로 희석하였고, 유기물을 이용하여 1,600, 2,000, 2,400의 배율로 희석하였다.The sterilization disinfectants of Examples 1 to 2 and Comparative Examples were immersed in hard water (containing 0.305 g of CaCl 2 and 0.139 g (w / v) of MgCl 2 .6H 2 O in 1 L of distilled water) and an organic material (fetal calf serum 5 % (v / v)) as follows. The disinfectant of Example 1 was diluted with water at 10,000, 16,000 and 20,000 magnifications, and the organic matter was diluted at a magnification of 2,000, 2,400 and 3,000. The disinfectant of Example 2 was diluted with water at 10,000, 16,000, and 20,000 magnifications and diluted with an organic material at 2,000, 2,400, and 3,000 magnifications. In addition, the sterilization disinfectant of the comparative example was diluted with water at 10,000, 16,000, and 20,000 magnifications, and diluted with organic matter at 1,600, 2,000, and 2,400 magnifications.

이후, 4℃에서 보관한 바이러스액 1.0mL(1×10~1×107EID50/mL)를 바이러스 희석용 용액인 경수 또는 유기물 19mL에 넣고 각각 혼합하였다. 상기 바이러스액 중 2.5mL를 취하여 동량의 실시예 1~2 및 비교예의 소독제 희석액이 들어 있는 시험관에 각각 넣어 혼합한 후(총 5mL) 4℃에서 정확히 30분간 반응시켰다. 이때, 각 시험관 처리는 차례대로 1분의 간격으로 실시하였으며, 반응 중 10분마다 흔들어주었다. 또한 병원체 대조군은 소독제 희석액이 없는 경수를 사용하였고, 독성 대조군은 경수로 희석된 소독제 희석액을 사용하였다.Thereafter, 1.0 mL (1 × 10 1 to 1 × 10 7 EID 50 / mL) of virus solution stored at 4 ° C. was added to 19 mL of hard water or organic matter, which is a virus dilution solution, and mixed. 2.5 mL of the virus solution was added to each test tube containing the same amount of the disinfectant solution of Examples 1 and 2 and the comparative example, respectively (5 mL in total), and reacted at 4 ° C for exactly 30 minutes. At this time, each test tube treatment was performed at intervals of 1 minute, and shaking was performed every 10 minutes during the reaction. The pathogen control group used hard water without sterilant diluent, and the toxic control group used light water diluted disinfectant diluent.

반응이 끝난 즉시 1mL을 꺼내어 미리 37℃에 넣어 놓은 5mL 중화배지(antibiotic·antimycotic을 함유한 RPMI-1640에 비동화된 소태아혈청 10%(v/v) 포함되게 조제)에 넣고 혼합하였다. 그 다음, 중화반응을 한 용액을 바이러스 배지(antibiotic·antimycotic을 함유한 RPMI-1640)를 사용하여, 원액, 10-1, 10-2, 10-3, 10-4, 10-5의 농도로 희석하고, 희석배율 당 8well의 monolayer(80~90%)가 형성된 MARC-145 cell에 각각 100μL씩 접종하였다. Immediately after the reaction was completed, 1 mL was taken out and mixed in 5 mL of neutralization medium (containing 10% (v / v) fetal bovine serum unmixed with RPMI-1640 containing antibiotic antimycotic) at 37 ° C in advance. Then, the neutralization reaction solution was diluted with a virus medium (RPMI-1640 containing antibiotic / antimycotic) at a concentration of 10 -1 , 10 -2 , 10 -3 , 10 -4 and 10 -5 Diluted and 100 μL each were inoculated into MARC-145 cells in which 8-well monolayer (80-90%) was formed per dilution magnification.

접종 후 37℃에서 5일 동안 배양하며 매일 CPE 형성 여부를 관찰하였고, Karber method로 바이러스 함유량을 계산하였다. After inoculation, the cells were incubated at 37 ° C for 5 days. CPE formation was observed daily, and the virus content was calculated by the Karber method.

병원체 대조군은 경수조건에서 소독제 없이 실험하고 중화반응 단계에서 병원체의 역가가 2×105TCID50/mL 이상임을 확인하였다. 독성대조군에서는 살균소독제에 의한 세포독성이 일어나지 않음을 확인하였다.The pathogen control was tested in the light water condition without the disinfectant and the neutralization reaction step confirmed that the activity of the pathogen was more than 2 × 10 5 TCID 50 / mL. In the toxic control group, it was confirmed that no cytotoxicity was caused by the disinfectant disinfectant.

4-5. 4-5. Foot and mouth disease virus(Foot and mouth disease virus ( FMD)에 대한 살균 소독력Sterilization disinfection power for FMD)

시험을 수행하기 전 Lamb kidney cell(L-glutamine, sodium bicarbonate, non-essential amino acid, sodium pyruvate, FBS 및 항생제가 첨가된 EMEM을 배양 배지로 사용)을 3×105cell/mL이 되도록 6 well plate에 분주하여 37℃, 5% CO2 배양기에서 배양하였다. 계대배양 중의 바이러스 역가가 107.0TCID50/mL 이상임이 확인된 FMD 바이러스를 사용직전까지 단시간 동안 4℃에 보관하였다.The test is carried out before Lamb kidney cell (L-glutamine, sodium bicarbonate, non-essential amino acid, sodium pyruvate, FBS and antibiotics using the addition of EMEM in the culture medium) to 3 × 10 5 cell / mL 6 well so that the , and cultured in a 5% CO 2 incubator at 37 ° C. The FMD virus, which was confirmed to have a virus titer of 10 7.0 TCID 50 / mL or higher during the subculture, was stored at 4 ° C for a short time until immediately before use.

상기 실시예 1~2 및 비교예의 살균소독제를 유기물 함유 경수(증류수 1 L에 CaCl2 0.304g과 MgCl2·6H2O 0.139g(w/v), FBS가 1%가 함유되게 조제)를 이용하여 다음과 같이 희석하였다. 실시예 1, 실시예 2 및 비교예의 살균소독제는 각각 100, 200, 300, 600, 900의 배율로 희석하였다.The sterilization disinfectants of Examples 1 to 2 and Comparative Examples were prepared by using an organic substance-containing water (prepared by adding 0.304 g of CaCl 2 and 0.139 g (w / v) of MgCl 2 .6H 2 O to 1 L of distilled water and containing 1% of FBS) And diluted as follows. The sterilization disinfectants of Examples 1, 2 and Comparative Example were diluted at a magnification of 100, 200, 300, 600 and 900, respectively.

이후, 4℃의 바이러스액 1.8mL(1×105~1×107TCID50/mL)를 최종 희석액보다 10배 농축된 소독제 희석액 0.2mL에 넣고 혼합한 후, 소독제 희석액과 바이러스액 혼합물을 4℃에서 30분간 반응시켰다. 반응이 끝나기 직전 바이러스와 소독제 희석액 혼합물(test mixture)을 잘 혼합하였다.Thereafter, 1.8 mL of the virus solution at 4 ° C (1 × 10 5 to 1 × 10 7 TCID 50 / mL) was added to 0.2 mL of a disinfectant diluted solution 10 times more concentrated than the final dilution, mixed with the disinfectant diluent and virus solution mixture 4 Lt; 0 > C for 30 minutes. The test mixture was thoroughly mixed with the virus and disinfectant immediately before the reaction was completed.

반응이 끝난 즉시 소독제를 중화하기 위하여 test mixture 0.05mL를 4℃ water bath에 보관된 중화배지(2% 항생제 및 5% FBS가 함유된 EMEM) 5mL에 첨가하였다. 상기 혼합액(final mixture)을 4℃의 중화배지를 이용하여 10배 계단희석(10-2~10-6)하였다. 음성대조군(증류수 접종), 양성대조군(NaOH 1%)을 포함한 각 희석배수 당 혼합액(final mixture) 0.2mL를 세포단층이 형성된 96 well plate에 접종하였다.To neutralize the disinfectant immediately after the reaction, 0.05 mL of the test mixture was added to 5 mL of neutralization medium (EMEM containing 2% antibiotic and 5% FBS) stored in a 4 ° C water bath. The final mixture was diluted 10-fold (10 -2 to 10 -6 ) 10 times with 4% neutralization medium. 0.2 mL of each final dilution, including the negative control (inoculated with distilled water) and the positive control (1% NaOH), was inoculated into a 96-well plate with a cell monolayer.

37℃, 5% CO2 습윤 배양기에서 1시간 동안 배양시키면서, 8~10분마다 잘 흔들어 주었다. 접종 1시간 후, 1% 메틸셀룰로오즈(methylcellulose)를 함유한 배지 2.5mL를 첨가한 후 37℃, 5% CO2 습윤 배양기에서 2일간 추가 배양하였다.And incubated for 1 hour at 37 ° C in a 5% CO 2 humidified incubator, shaking well every 8 to 10 minutes. After 1 hour of inoculation, 2.5 mL of a medium containing 1% methylcellulose was added, followed by further incubation for 2 days in a 5% CO 2 humidified incubator at 37 ° C.

배양 후 0.01~0.05% 시트르산(citric acid)으로 세포를 세척하고 아미도블랙(amidoblack)으로 염색한 후, 플라크(plaque) 수를 계수하여 PFU 값을 산출하였다.After incubation, the cells were washed with 0.01-0. 5% citric acid and stained with amidoblack. The number of plaques was counted to calculate the PFU value.

4-6. 실험결과4-6. Experiment result

상기 4-1 내지 4-5에서 실험한 살균소독력 시험결과는 병원체 대조군과 비교하여 유효희석배수를 확인하였다. 즉, 병원체 대조군과 비교하여 병원체가 104(최소 4 log10) 이상의 감소가 확인된 희석배수를 유효희석배수로 결정하였다. 3회 반복 시험하여 20%의 오차범위 내의 결과의 중위수(median)를 공시제품에 대한 최종 유효희석배수로 결정하였다. 그 결과는 하기 표 4에 나타내었다. The results of the sterilization test on 4-1 to 4-5 were compared with the pathogen control to confirm the effective dilution factor. That is, the dilution factor was determined as the effective dilution factor, which was confirmed to decrease by at least 10 log 4 (at least 4 log10) compared to the pathogen control. The median of the results within an error range of 20% was determined as the final effective dilution factor for the disclosed product three times. The results are shown in Table 4 below.

Figure 112016036246608-pat00003
Figure 112016036246608-pat00003

상기 표 4에 나타낸 바와 같이, 본 발명의 염소계 살균소독제는 조류인플루엔자바이러스(Avian influenza virus, AI), 뉴캐슬병바이러스(Newcastle disease virus, ND), 돼지 유행성 설사증 바이러스(Porcine epidemic diarrhea virus, PED), 돼지 호흡기 및 생식 증후군 바이러스(Porcine respiratory and reproductive syndrome virus, PRRS), 구제역 바이러스(Foot and mouth disease virus, FMD) 등의 바이러스에 대하여 우수한 살균소독력을 나타내었으며, 비교예 1과 대비하여 염소취가 전혀 없으면서도 유사한 수준의 희석배율에서 유효한 살균소독력을 나타냄을 확인할 수 있었다.As shown in Table 4 above, the chlorine-based disinfectant of the present invention is effective against avian influenza viruses ( Avian influenza virus , AI), Newcastle disease ( Newcastle disease virus, ND), porcine epidemic diarrhea virus (Porcine epidemic diarrhea virus, PED) , porcine respiratory and reproductive syndrome virus (Porcine respiratory and reproductive syndrome virus, PRRS), foot-and-mouth disease virus (Foot and mouth disease virus, FMD ) such as viruses And showed an effective disinfecting power at a dilution ratio similar to that of Comparative Example 1, even when there was no chlorine odor.

비록 본 발명이 상기에 언급된 바람직한 실시예로서 설명되었으나, 발명의 요지와 범위로부터 벗어남이 없이 다양한 수정이나 변형을 하는 것이 가능하다. 또한 첨부된 청구 범위는 본 발명의 요지에 속하는 이러한 수정이나 변형을 포함한다.Although the present invention has been described in terms of the preferred embodiments mentioned above, it is possible to make various modifications and variations without departing from the spirit and scope of the invention. It is also to be understood that the appended claims are intended to cover such modifications and changes as fall within the scope of the invention.

Claims (5)

이염화이소시아눌산나트륨; 및
설파믹산 또는 과산화나트륨과 설파믹산의 혼합물 중 선택된 어느 하나의 성분;을 포함하는 염소취가 제거된 염소계 살균소독제 조성물.
Sodium dicarboxylate isocyanurate; And
Wherein the chlorine-free disinfecting composition comprises any one selected from the group consisting of sulfamic acid or a mixture of sodium peroxide and sulfamic acid.
제1항에 있어서,
상기 염소계 살균소독제 조성물은 살모넬라 타이피뮤리움(Salmonella typhimurium), 브루셀라 오비스(Brucella ovis), 클로스트리디움 퍼프리젠스(Clostridium perfringens), 조류인플루엔자바이러스(Avian influenza virus, AI), 뉴캐슬병바이러스(Newcastle disease virus, ND), 돼지 유행성 설사증 바이러스(Porcine epidemic diarrhea virus, PED), 돼지 호흡기 및 생식 증후군 바이러스(Porcine respiratory and reproductive syndrome virus, PRRS) 및 구제역 바이러스(Foot and mouth disease virus, FMD) 중 선택된 어느 하나 이상의 살균 또는 소독 용도인 것을 특징으로 하는 염소취가 제거된 염소계 살균소독제 조성물.
The method according to claim 1,
The chlorine-based disinfecting composition may be selected from the group consisting of Salmonella typhimurium , Brucella ovis , Clostridium perfringens , Avian influenza virus (AI), Newcastle disease virus , ND), porcine epidemic diarrhea virus (Porcine epidemic diarrhea virus, PED) , swine respiratory and reproductive syndrome virus (Porcine respiratory and reproductive syndrome virus, PRRS) and foot-and-mouth disease virus (least any one selected from Foot and mouth disease virus, FMD) Wherein the chlorine-free sterilizing agent is used for sterilization or disinfection.
삭제delete 제1항에 있어서,
조성물 총 100중량부에 대하여 이염화이소시아눌산나트륨 50~80중량부; 및 설파믹산 또는 과산화나트륨과 설파믹산의 혼합물 중 선택된 어느 하나의 성분 10~50중량부;를 포함하는 것을 특징으로 하는 염소취가 제거된 염소계 살균소독제 조성물.
The method according to claim 1,
50 to 80 parts by weight of sodium dichloroisocyanurate sodium based on 100 parts by weight of the total composition; And 10 to 50 parts by weight of one selected from the group consisting of sulfamic acid or a mixture of sodium peroxide and sulfamic acid.
제1항에 있어서,
상기 조성물은 비타민 C(ascobic acid), 과산화수소(hydrogen peroxide), 탄산수소나트륨(sodium bicarbonate), 탄산나트륨(sodium carbonate) 및 구연산(citric acid) 중 선택된 어느 하나 이상의 성분을 추가로 포함하는 것을 특징으로 하는 염소취가 제거된 염소계 살균소독제 조성물.
The method according to claim 1,
The composition may further comprise at least one selected from the group consisting of ascorbic acid, hydrogen peroxide, sodium bicarbonate, sodium carbonate, and citric acid. A chlorine-based disinfecting composition comprising chlorine removed.
KR1020160046238A 2016-04-15 2016-04-15 Composition of chlorine disinfections free of chlorine smell KR101857736B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160046238A KR101857736B1 (en) 2016-04-15 2016-04-15 Composition of chlorine disinfections free of chlorine smell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160046238A KR101857736B1 (en) 2016-04-15 2016-04-15 Composition of chlorine disinfections free of chlorine smell

Publications (2)

Publication Number Publication Date
KR20170118442A KR20170118442A (en) 2017-10-25
KR101857736B1 true KR101857736B1 (en) 2018-05-14

Family

ID=60300012

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160046238A KR101857736B1 (en) 2016-04-15 2016-04-15 Composition of chlorine disinfections free of chlorine smell

Country Status (1)

Country Link
KR (1) KR101857736B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019156785A (en) * 2018-03-15 2019-09-19 学校法人 京都産業大学 Antiseptic to influenza virus and its production method, and, deactivation method of influenza virus
KR20210076466A (en) 2019-12-16 2021-06-24 박준호 Bactericidal disinfectant composition comprising sodium hypochlorite as an active ingredient and method for preparing thereof
CN113133461B (en) * 2021-04-05 2024-01-09 安徽理想种业有限公司 Liquid medicine composition for removing black rice husk powder from rice seeds and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003096810A1 (en) 2002-05-22 2003-11-27 Kurita Water Industries Ltd. Composition for prevention of slime and method for preventing slime
JP2011173858A (en) 2009-12-03 2011-09-08 Tomita Pharmaceutical Co Ltd Hypochlorous acid-based germicidal disinfectant, and method and apparatus for preparing the same
WO2015073170A1 (en) * 2013-11-12 2015-05-21 Ecolab Usa Inc. Composition and method for biofouling inhibition of membrane separation device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003096810A1 (en) 2002-05-22 2003-11-27 Kurita Water Industries Ltd. Composition for prevention of slime and method for preventing slime
JP2011173858A (en) 2009-12-03 2011-09-08 Tomita Pharmaceutical Co Ltd Hypochlorous acid-based germicidal disinfectant, and method and apparatus for preparing the same
WO2015073170A1 (en) * 2013-11-12 2015-05-21 Ecolab Usa Inc. Composition and method for biofouling inhibition of membrane separation device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Chem. Rev., 1980, Vol.80, pp.151-186(1980.04.)*

Also Published As

Publication number Publication date
KR20170118442A (en) 2017-10-25

Similar Documents

Publication Publication Date Title
KR101649387B1 (en) Antibacterial composition and antiviral composition each containing silicon-containing compound, antibacterializing method, cleaning/mouth cleaning method, and method for immobilizing antibacterial agent or antiviral agent
JP2007530731A (en) Hypochlorite dilution method
KR101857736B1 (en) Composition of chlorine disinfections free of chlorine smell
KR100772054B1 (en) Composition for sterilization of pathogenic avian influenza
CN105836860B (en) A kind of stable type dioxygen aqueous disinfectant and its application in drinking water disinfection
CN1907500A (en) Disinfection agent of chlorine dioxide
CN103503922A (en) Disinfection powder for hospital wastewater disinfection
KR100876684B1 (en) Preparation method of acidic antibiotic composition containing peracid and acetyl salicylic acid
KR20190115372A (en) Method and apparatus for producing of pure chlorite solution
KR100669204B1 (en) Composition for deodorization and sterilization and its manufacturing process
KR101286088B1 (en) Method for Preparing Hypochlorous Acid Water with High Stability
KR20120101420A (en) Microbiocidal control in drinking line systems
CN109954396A (en) A kind of sterilizing deodorization agent of livestock and poultry cultivation
CN106689194A (en) Sustained-release disinfectant fluid
KR101948738B1 (en) Anti-freezing disinfectant composite and method for preventing disease and spread using the same
CN101606534B (en) Bromine-containing disinfecting agent
JP7073593B1 (en) Antibacterial, antifungal, antiviral disinfectant composition
KR20140113104A (en) Eco-Friendly Composition having Deodorization and Sterilization and its a manufacturing method
CN102948426B (en) Novel food safety grade disinfection solution and preparation method thereof
WO2018212399A1 (en) Hypochlorous acid sterilizing water composition
CN111202088A (en) Chlorhexidine acetate disinfectant and preparation method and application thereof
CN108522538A (en) A kind of water disinfectant
CN113170801A (en) Disinfectant and preparation method and application thereof
RU2475268C1 (en) Disinfecting preparation
Sojitra et al. Saltwater as a Disinfectant and Cleaning agent for Environmental Surfaces in the context of SARS-COV-II.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant